Total Payments
$1,731
2024 Payments
$1,234
Companies
18
Transactions
52
Medicare Patients
131
Medicare Billing
$7,043

Payment Breakdown by Category

Food & Beverage$1,731 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,731 52 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $397.13 6 $0 (2024)
GlaxoSmithKline, LLC. $349.07 18 $0 (2024)
GENZYME CORPORATION $182.95 5 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $144.13 2 $0 (2024)
Shionogi Inc $124.92 1 $0 (2024)
ANI Pharmaceuticals, Inc. $121.61 1 $0 (2023)
ABBVIE INC. $67.35 3 $0 (2023)
HARMONY BIOSCIENCES LLC $56.58 2 $0 (2024)
Amgen Inc. $49.41 2 $0 (2024)
Mylan Specialty L.P. $40.45 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,234 31 AstraZeneca Pharmaceuticals LP ($381.71)
2023 $419.31 16 ANI Pharmaceuticals, Inc. ($121.61)
2022 $78.29 5 Boehringer Ingelheim Pharmaceuticals, Inc. ($22.59)

All Payment Transactions

52 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/22/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $10.16 General
Category: RESPIRATORY
11/22/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $2.80 General
Category: RESPIRATORY
11/14/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $3.82 General
Category: RESPIRATORY
11/08/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $24.86 General
Category: Anticholinergics, Inhaled
11/08/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $9.15 General
Category: RESPIRATORY
11/08/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $2.97 General
Category: Respiratory
10/18/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.84 General
Category: Immunology
09/11/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $120.65 General
Category: Respiratory
09/04/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $2.30 General
Category: RESPIRATORY
08/26/2024 CSL Behring Kcentra (Biological) Food and Beverage In-kind items and services $33.20 General
Category: Trauma (Emergency, Injury, Surgery)
08/09/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $3.42 General
Category: RESPIRATORY
07/25/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $15.59 General
Category: Anticholinergics, Inhaled
07/24/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.60 General
Category: Immunology
07/22/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $21.87 General
Category: IMMUNOLOGY
07/19/2024 Amgen Inc. TEZSPIRE (Biological) Food and Beverage In-kind items and services $26.69 General
Category: Inflammation
07/16/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $17.76 General
Category: Respiratory
07/09/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $9.21 General
Category: Immunology
06/27/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $28.36 General
Category: Narcoplepsy
06/18/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $8.93 General
Category: Immunology
06/12/2024 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $125.13 General
Category: Respiratory
06/11/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $121.54 General
05/29/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $21.17 General
Category: IMMUNOLOGY
05/28/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.53 General
Category: RESPIRATORY
05/28/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $5.78 General
Category: RESPIRATORY
05/08/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $123.37 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 119 169 $28,300 $6,449
2022 1 12 14 $2,926 $593.47
Total Patients
131
Total Services
183
Medicare Billing
$7,043
Procedure Codes
3

All Medicare Procedures & Services

3 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 71 108 $15,551 $3,917 25.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 48 61 $12,749 $2,532 19.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 12 14 $2,926 $593.47 20.3%

About Abigail Graves

Abigail Graves is a Student in an Organized Health Care Education/Training Program healthcare provider based in Cambridge, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2022. The National Provider Identifier (NPI) number assigned to this provider is 1003551128.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abigail Graves has received a total of $1,731 in payments from pharmaceutical and medical device companies, with $1,234 received in 2024. These payments were reported across 52 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,731).

As a Medicare-enrolled provider, Graves has provided services to 131 Medicare beneficiaries, totaling 183 services with total Medicare billing of $7,043. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.

Practice Information

Products in Payments

  • DUPIXENT (Biological) $182.95
  • TEZSPIRE (Biological) $151.82
  • AIRSUPRA (Drug) $135.93
  • AREXVY (Drug) $134.20
  • Fetroja (Drug) $124.92
  • TRELEGY ELLIPTA (Drug) $123.44
  • PURIFIED CORTROPHIN GEL (Drug) $121.61
  • FASENRA (Biological) $120.65
  • NUCALA (Biological) $91.43
  • WAKIX (Drug) $56.58
  • UBRELVY (Drug) $45.63
  • YUPELRI (Drug) $40.45
  • Kerendia (Drug) $37.61
  • Nayzilam (Drug) $36.65
  • Kcentra (Biological) $33.20
  • Otezla (Drug) $22.72
  • VIBERZI (Drug) $21.72
  • NURTEC ODT (Drug) $17.30
  • XTAMPZA (Drug) $16.31
  • XYOSTED (Drug) $16.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Cambridge